{"entity":{"id":"nct00563836","kind":"trial","name":"Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer","aka":[],"tldr":"A phase 2 trial of Catumaxomab in Ovarian cancer, run by Neovii Biotech, completed.","summary":"Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer is a phase 2 interventional study registered as NCT00563836 by Neovii Biotech, with 41 participants recorded, started 2007-11 and reaching its primary completion in 2008-09. Interventions recorded: Catumaxomab. Conditions recorded: Ovarian Cancer, Epithelial Ovarian Cancer.\n\nLinked to the drug Catumaxomab because the registry names it among its interventions and Ovarian cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00563836","url":"https://clinicaltrials.gov/study/NCT00563836"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":["catumaxomab"],"companies":["neovii"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00563836","phase":"2","setting":"Multicenter, Single-arm, Phase II Study of the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3) Administered Intra- and Postoperatively in Patients With Epithelial Ovarian Cancer","sponsor":"Neovii Biotech","participation":[{"nct":"NCT00563836","source":"https://clinicaltrials.gov/study/NCT00563836","fetchedAt":"2026-10-07T16:52:08.840Z","studySha256":"d5db30726c0013b7aa61f08e41d23a542d56df5685d45f0b76c216a9977a4a20","overallStatus":"COMPLETED","lastUpdatePosted":"2012-10-03","leadSponsor":"Neovii Biotech","collaboratorCount":0,"minimumAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":41,"enrolmentType":"ESTIMATED","siteCount":2,"recruitingSiteCount":0,"countries":["Austria","Germany"]}],"started":"2007-11","enrolled":41,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00563836/","neighbours":{"cancer":[{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"drug":[{"id":"catumaxomab","kind":"drug","name":"Catumaxomab","route":"/drugs/catumaxomab/"}],"company":[{"id":"neovii","kind":"company","name":"Neovii","route":"/companies/neovii/"}]}}